Equity Profile

OSCR

Oscar Health, Inc.

FinancialsLife & Health Insurance$9.5B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Oscar Health, Inc. is a health insurance company focused on providing affordable and accessible healthcare coverage....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and revenues.

$-0.23

Revenue

Total revenue reflects the company's ability to attract and retain customers, which is crucial for growth in the competitive health insurance market.

$4.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

OSCR Q2-2026 Earnings Preview

Context

Company Snapshot

Oscar Health, Inc. is a health insurance company focused on providing affordable and accessible healthcare coverage. Operating in the Financials sector, it leverages technology to improve customer experience and streamline operations, which is increasingly important as consumers seek better healthcare solutions.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-38.79%

Avg Stock Reaction

+2.43%

Last Quarter Recap

In Q1-2026, Oscar Health reported an EPS of $2.07, significantly beating estimates by 71%. The stock reacted positively, gaining over 10% the following day.

Management Promises & Guidance

Focus on improving customer satisfaction through enhanced digital tools.
Commitment to expanding market presence in key states.
Plans to reduce operational costs while maintaining service quality.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Oscar Health's upcoming earnings, with expectations for a slight loss in EPS but solid revenue growth.

Bull Case

If Oscar can exceed revenue expectations and show improvements in customer retention, it could signal strong operational momentum and boost investor confidence.

Bear Case

Conversely, if the company fails to meet revenue targets or shows worsening losses, it may raise concerns about its long-term viability and market competitiveness.

Key Metrics to Watch

EPS

$-0.23

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and revenues.

Revenue

$4.7B

Total revenue reflects the company's ability to attract and retain customers, which is crucial for growth in the competitive health insurance market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Oscar Health's revenue exceed the consensus estimate of $4.7B?

Revenue growth is critical for demonstrating the company's ability to attract and retain customers in a competitive market.

How will management address the expected EPS loss of $-0.23?

Investors will closely watch for any insights on cost management and operational efficiency that could impact future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Oscar's ability to leverage technology for cost savings, which could lead to better-than-expected revenue growth.

Supporting Evidence

The company has shown a strong ability to surprise on EPS in previous quarters, indicating potential for positive surprises.

Options pricing suggests traders are expecting a larger move than historical averages, indicating potential for volatility.

Recent operational improvements may not be fully reflected in analyst estimates.

Key Risk

If revenue comes in above $4.7B, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for growth against the backdrop of ongoing losses, making this quarter's results particularly pivotal.

Bull Confirmed If

Revenue growth above $4.7B with a clear path to profitability could confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.23 and revenue below $4.5B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.89%

Historical Avg

±9.2%

Pricing rich

The options market is pricing in a significant move, suggesting traders expect volatility around the earnings report.

Options are pricing ±14.9% while OSCR has averaged ±9.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

58.0%

Calls (691K)P/C Ratio: 0.17Puts (348K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Oscar beats expectations, history suggests a potential stock increase of around 8.74%, confirming positive operational momentum.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience a muted reaction, reflecting uncertainty.

Miss

A miss could lead to a decline of about 3.89%, as investors reassess the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer acquisition strategies and their effectiveness.
2Details on cost management initiatives and their impact on profitability.
3Any commentary on competitive pressures in the health insurance market.
4Insights into technology investments and their expected ROI.
5Management's outlook on future growth and market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug7

PAABMO

Plains All American Pipeline, L.P.

PreviewView

Aug7

ESNTBMO

Company Snapshot

Oscar Health, Inc. is a health insurance company focused on providing affordable and accessible healthcare coverage....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and revenues.

$-0.23

Revenue

Total revenue reflects the company's ability to attract and retain customers, which is crucial for growth in the competitive health insurance market.

$4.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

OSCR Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

-38.79%

Avg Stock Reaction

+2.43%

Last Quarter Recap

In Q1-2026, Oscar Health reported an EPS of $2.07, significantly beating estimates by 71%. The stock reacted positively, gaining over 10% the following day.

Management Promises & Guidance

Focus on improving customer satisfaction through enhanced digital tools.
Commitment to expanding market presence in key states.
Plans to reduce operational costs while maintaining service quality.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Oscar Health's upcoming earnings, with expectations for a slight loss in EPS but solid revenue growth.

Bull Case

If Oscar can exceed revenue expectations and show improvements in customer retention, it could signal strong operational momentum and boost investor confidence.

Bear Case

Conversely, if the company fails to meet revenue targets or shows worsening losses, it may raise concerns about its long-term viability and market competitiveness.

Key Metrics to Watch

EPS

$-0.23

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and revenues.

Revenue

$4.7B

Total revenue reflects the company's ability to attract and retain customers, which is crucial for growth in the competitive health insurance market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Oscar Health's revenue exceed the consensus estimate of $4.7B?

Revenue growth is critical for demonstrating the company's ability to attract and retain customers in a competitive market.

How will management address the expected EPS loss of $-0.23?

Investors will closely watch for any insights on cost management and operational efficiency that could impact future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Oscar's ability to leverage technology for cost savings, which could lead to better-than-expected revenue growth.

Supporting Evidence

The company has shown a strong ability to surprise on EPS in previous quarters, indicating potential for positive surprises.

Options pricing suggests traders are expecting a larger move than historical averages, indicating potential for volatility.

Recent operational improvements may not be fully reflected in analyst estimates.

Key Risk

If revenue comes in above $4.7B, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the potential for growth against the backdrop of ongoing losses, making this quarter's results particularly pivotal.

Bull Confirmed If

Revenue growth above $4.7B with a clear path to profitability could confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.23 and revenue below $4.5B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±14.89%

Historical Avg

±9.2%

Pricing rich

The options market is pricing in a significant move, suggesting traders expect volatility around the earnings report.

Options are pricing ±14.9% while OSCR has averaged ±9.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

58.0%

Calls (691K)P/C Ratio: 0.17Puts (348K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Oscar beats expectations, history suggests a potential stock increase of around 8.74%, confirming positive operational momentum.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience a muted reaction, reflecting uncertainty.

Miss

A miss could lead to a decline of about 3.89%, as investors reassess the company's growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on customer acquisition strategies and their effectiveness.
2Details on cost management initiatives and their impact on profitability.
3Any commentary on competitive pressures in the health insurance market.
4Insights into technology investments and their expected ROI.
5Management's outlook on future growth and market expansion plans.